The $6.3 billion LBO of medical device maker Kinetic Concepts Inc. by an Apax Partners LLP-led consortium is "probably the beginning of a good two or three year run of run" in medtech, says Piper Jaffray & Co.'s Matt Miksic in this video interview with The Deal Pipeline's David Holley. According to Miksic, deals such as Johnson & Johnson's $21.3 billion cash-and-stock offer for Synthes Inc.  and Stryker Corp.'s $1.4 billion purchase of Boston Scientific Corp.'s neurovascular division are indicative of a changing economic environment that may result in many more large deals in the industry. - George White